BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Japan

Jadeite Medicines Granted Orphan Drug Designation and Initiates Phase 3 Trial for Odevixibat in PFIC by Japanese Ministry of Health

This Phase 3 trial will evaluate the efficacy and safety of an oral dosage of odevixibat in Japanese PFIC patients. Odevixibat is marketed by Ipsen Pharma ...

June 21, 2023 | News

FDA Approves Japan's Cardio Flow Design's Innovative 4D Flow MRI Software

The US Food and Drug Administration has approved the use of iTFlow® in blood flow analysis. The FDA approval is significant as it recognizes the safety...

June 20, 2023 | News

ACROBiosystems Broadens Custom GMP-grade Protein Services for CGT Advancement and Commercialization

To support the commercialization of cell therapies, ACROBiosystems is now offering a global custom GMP-grade protein services. As part of their service pla...

June 08, 2023 | News

Olympus to Establish Digital Excellence Centers After Odin Vision Acquisition

Olympus, a global MedTech company committed to making people's lives healthier, safer and more fulfilling, announced the plan to establish a series o...

June 06, 2023 | News

Shimadzu Collaborates with Osaka University, Hires Master's Graduates for Joint Research

Shimadzu and Osaka University have been collaborating to help Shimadzu engineers and researchers obtain doctoral degrees within the REACH Lab Project since...

June 01, 2023 | News

Merck Study: mRNA Technology a ‘Game Changer’ for Asia-Pacific Vaccine Manufacturers

87% of respondents deemed mRNA a key modality for the future More than 60% of vaccine makers surveyed plan revamp or new facilities for mRNA m...

June 01, 2023 | News

Keio and Osaka Universities Present Non-Clinical Data on Stable/Functional-Induced Regulatory T Cells in Autoimmune Models

Their presentation demonstrated that in a murine pemphigus model, S/F-iTregs significantly decreased clinical scores, circulating anti-Dsg3 IgG titers, and...

May 30, 2023 | News

Catalent Enhances Cryogenic Capabilities in Japan Facility for Cell and Gene Therapy Development

State-of-the-art cryogenic freezers alongside material transfer equipment have been installed that are designed to retain the integrity of investigational ...

May 25, 2023 | News

Ajinomoto Bio-Pharma Services Announces Leadership Changes at US Facility

Along with these additions to the site leadership team, the company has also appointed Erik Riley as Senior Vice President, Corporate Planning. T...

May 19, 2023 | News

Fujitsu launches "Biodrug Design Accelerator" platform to accelerate peptide drug discovery research

Fujitsu today announced the commercial debut of its "Biodrug Design Accelerator," a platform to manage research processes for peptide (1) drug discovery, w...

May 18, 2023 | News

Fujitsu partners with Takeda and National Cancer Center Japan to analyze and visualize ovarian cancer patient journey

Fujitsu today announced that it has conducted a joint research project with Takeda Pharmaceutical Company Limited and the National Cancer Center Japan to a...

May 12, 2023 | News

Gencurix Reports Clinical Results of 15-Year Follow-Up Prognostic Test for Cancer Patients in Korea and Japan

Gencurix announced clinical results of its prognostic test for breast cancer patients at the Global Breast Cancer Conference 2023. The study, 'Long-te...

May 10, 2023 | News

Ubie Teams Up with Google's Android Health Connect (Beta) for Japan Launch

Users who agree to share data, such as blood sugar levels, on Health Connect (Beta) can benefit from improved accuracy of symptom-related questions in Ubie...

May 10, 2023 | News

Telix to Provide Illuccix® to Bayer for Global Phase III Prostate Cancer Study, Including Japan

This global study is investigating the efficacy of Bayer's androgen receptor inhibitor (ARi) darolutamide plus androgen deprivation therapy (ADT) versus AD...

May 08, 2023 | News

Stay Connected